The Department of the Army Medical Command has awarded Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory, a 5-year Blanket Purchase Agreement (BPA) to provide NEOTYPE SOLID TUMOR TESTING AND REPEAT FISH TESTING at Tripler Army Medical Center in Hawaii. The BPA has a potential value of $1,000,000.00 and covers the period from April 1, 2019 to March 11, 2024. Through this single-award IDV, Neogenomics will furnish specialized cancer testing and diagnostic services, including genomic sequencing, flow cytometry, and cytogenetic analysis, to support patient care at the military treatment facility. Neogenomics has extensive experience delivering laboratory testing services to federal healthcare systems, including the Department of Veterans Affairs and Indian Health Service, through various IDV and BPA contract vehicles. This award enables Neogenomics to continue supporting the medical readiness and health of military service members and their families treated at Tripler Army Medical Center.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 12/3/21 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 10/21/20 | |
| Not listed | Not listed | $0 | 3/6/19 |
Name | Description | Solicitation Number | Federal Agency | Type | Posted Date (Click to sort descending) |
|---|---|---|---|---|---|
Reagents | W81K02-19-Q-0005 | Department of the Army Medical Command | Award Notice 2/2 | 9/24/19, 1:19 PM | |
NEOTYPE SOLID TUMOR TESTING AND REPEAT FISH TESTING AT TRIPLER ARMY MEDICAL CENTER, HI | W81K02-19-Q-0005 | Department of the Army Medical Command | Award Notice 1/2 | 11/13/18, 3:59 PM |